Management of Parkinson's Disease Dementia: Practical Considerations

ISSN： 1170-229X

Source： Drugs & Aging, Vol.23, Iss.10, 2006-01, pp. : 807-822

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine in Parkinson's disease dementia

By Chitnis Shilpa Rao Jayaraman

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 941-955

Informa Healthcare

Access to resources Recommend Favorite

Rivastigmine: In Parkinson's Disease Dementia

By Siddiqui M. Asif A. Wagstaff Antona J.

CNS Drugs, Vol. 20, Iss. 9, 2006-01 ,pp. : 739-747

Adis International

Access to resources Recommend Favorite

Treatment of Dementia with Lewy Bodies and Parkinson's Disease Dementia

By Ballard Clive

Drugs & Aging, Vol. 28, Iss. 10, 2011-10 ,pp. : 769-777

Adis International

Access to resources Recommend Favorite

Pharmacological Management of Parkinson's Disease

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 34, Iss. 3, 2004-09 ,pp. : 229-232

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Surgical Management of Parkinson's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 6, 2011-09 ,pp. : 685-692

Bentham Science Publishers

Access to resources Recommend Favorite